Ricevi le ultime notizie sulle azioni Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di THNR

Ultime notizie per

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

Healthcare

Consumer Defensive

The Index is comprised of global companies expected to economically benefit from weight loss drug development. The Index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs.

Eli Lilly & Co.

Novo Nordisk A/S ADR

Developed Markets Astrazeneca Plc Sponsored Adr

Amgen Inc.

Pfizer, Inc.

Chugai Pharmaceutical Co. Ltd. Com Stk

Roche Holding Ag

Merck & Co. Inc.

West Pharmaceutical Services Inc

Thermo Fisher Scientific Inc

Innovent Biologics Inc

Teva Pharmaceutical Industries Ltd

Hims & Hers Health Inc

Regeneron Pharmaceuticals, Inc.

Gilead Sciences Inc

Abbvie Inc.

Amplify Weight Loss Drug & Treatment ETF

Comments

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF Notizie sulle azioni

Notizie

Ultime notizie per

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO